Standout Papers

Overview of the main outcomes in breast-cancer prevention trials 2003 2026 2010 2018 678
  1. Overview of the main outcomes in breast-cancer prevention trials (2003)
    Jack Cuzick, T.J. Powles et al. The Lancet

Immediate Impact

5 by Nobel laureates 5 from Science/Nature 72 standout
Sub-graph 1 of 21

Citing Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
2022 Standout
9 intermediate papers

Works of Robert P. Edwards being referenced

Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles
2018
Modulation of CD3-zeta as a marker of clinical response to IL-2 therapy in ovarian cancer patients
2004
and 7 more

Author Peers

Author Last Decade Papers Cites
Robert P. Edwards 2611 2672 3787 2765 306 11.6k
Michael Quinn 3130 2162 3626 1180 335 12.4k
Sërgio Pecorelli 4103 3770 2852 1521 177 10.3k
Peter E. Schwartz 3087 2007 3299 1307 255 10.0k
Gemma G. Kenter 3371 3498 5152 4925 230 14.1k
Peter Kenemans 2643 1501 2365 2149 303 11.4k
Takayuki Enomoto 2674 2507 2494 1039 363 8.9k
Leon F.A.G. Massuger 3436 2455 2701 1031 359 12.4k
Ronald D. Alvarez 3055 2638 4238 1596 340 12.3k
Clemens Tempfer 2513 1895 1899 1291 366 8.9k
Ross S. Berkowitz 5343 2840 2702 1682 437 18.3k

All Works

Loading papers...

Rankless by CCL
2026